1 / 3

Myasthenia Gravis Disease Market

Myasthenia Gravis Disease Market Research Report - Forecast to 2023

Rohitravan
Download Presentation

Myasthenia Gravis Disease Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. 2019 Myasthenia Gravis Disease Market Current Updates, Industry Size, Top Key Players, Future Trends, Regional Growth Analysis To 2023 – Clinical Assessment on Clinical Manifestations The Global Myasthenia Gravis Disease Market is expected to exhibit a strong CAGR of 7.5% over the forecast period from 2017 to 2023, according to the latest research report from Market Research Future (MRFR). Myasthenia gravis is a neuromuscular disorder that leads to the weakening of skeletal muscles, which are responsible for the movement of the body. This condition occurs due to the impairment of communication between muscles and nerve cells. This impairment causes difficulties in the contraction and relaxation of muscles which are crucial for carrying out daily activities, resulting in muscle weakness Competitive Analysis: Leading players in the global myasthenia gravis disease market include – Fresenius Kabi GSK plc AbbVie Inc. Biogen Inc. Bristol-Myers Squibb Co. F. Hoffman-La Roche Ltd. Cipla RPG Life Sciences Teva Pharmaceutical Industries Ltd. Apotex Corporation Novartis Piramal Healthcare Sun Pharmaceuticals Industries Ltd. Valeant. Research projects are likely to be crucial for the global myasthenia gravis disease market over the forecast period. In July 2019, a new case report from a man suffering from both multiple sclerosis and myasthenia gravis showed that the two diseases may share common autoimmune responses. Market Research Future

  2. Avail FREE Sample at https://www.marketresearchfuture.com/sample_request/5843 In August 2019, a research team from Chongqing Medical University and SUNY Upstate Medical University found that gut microbes and metabolic changes could provide an accurate biomarker for myasthenia gravis disease. Such efforts are likely to remain crucial for the global myasthenia gravis disease market over the forecast period. Segmentation: The global myasthenia gravis disease market has been segmented on the basis of diagnosis, treatment, and end-user. On the basis of diagnosis, the global myasthenia gravis disease market can be segmented into imaging, blood tests, electrodiagnostic, edrophonium tests, pulmonary function tests, and others. The imaging segment is classified into X-ray, computed tomography (CT), magnetic resonance imaging (MRI), and others. On the basis of treatment, the global myasthenia gravis disease market can be segmented into medication, surgery, autologous hematopoietic stem cell transplantation (HSCT), plasmapheresis and intravenous immunoglobulin, and others.By medication, the market is divided into acetylcholinesterase inhibitors, immunosuppressants, steroids, and others. The acetylcholinesterase inhibitors segment is further classified into atropine, neostigmine, pyridostigmine, and others. Immunosuppressant drugs are further divided into azathioprine, mycophenolate mofetil, tacrolimus, and rituximab. The steroids segment is further divided into prednisone and others. Surgery is divided into thymectomy and others. On the basis of end user, the global myasthenia gravis disease market is segmented into hospitals, clinics, academic research institutes, and others. Browse Complete Report Details at https://www.marketresearchfuture.com/reports/myasthenia- gravis-disease-market-5843 Regional Analysis: The global myasthenia gravis disease market is expected to be dominated by North America over the forecast period, with the Americas segment holding the dominant share in the market. The Americas market for myasthenia gravis disease is mainly driven by the growing awareness about the disease, as neurological diseases have been studied in detail in the region and awareness about this kind of disease is significantly high in the region. The growing demand for effective medications for neuromuscular diseases such as myasthenia gravis is likely to drive the drug development scenario in the Americas region over the forecast period, leading to steady growth of the myasthenia gravis disease market. Europe holds the second largest share in the global myasthenia gravis disease market and is likely to remain a leading contender in the global market over the forecast period due to the growing awareness about neuromuscular conditions. Myasthenia gravis holds a significant position in the Europe market, as the disease can cause a significant burden on national healthcare systems. The increasing financial burden of myasthenia gravis disease is likely to drive the myasthenia gravis disease market in Europe over the forecast period. Market Research Future

  3. Asia Pacific is likely to be a major regional market for myasthenia gravis disease over the forecast period due to the growing awareness about the disease and the increasing desire to eliminate the disease from urban populations in growing economies such as China, India, Japan, and South Korea. Increasing healthcare expenditure in the region is likely to be a major driver for the myasthenia gravis disease market over the forecast period. Rising awareness about neuromuscular diseases is likely to be a key driver for the myasthenia gravis disease market in Asia Pacific over the forecast period. Ask for an Exclusive Discount on this Report The Middle East and Africa is likely to retain a low share in the global myasthenia gravis disease market over the forecast period due to the lack of awareness about the disease in the region and the low disposable income of consumers in the region. About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. Contact: Market Research Future +1 646 845 9312 Email: sales@marketresearchfuture.com Market Research Future

More Related